Regenstrief leaders share their expertise in artificial intelligence at workshop in South America

NewsGuard 100/100 Score

Two of Regenstrief Institute's leaders are sharing their expertise in artificial intelligence and data infrastructure at a workshop hosted by Brazil's National Institute of Science and Technology in Scientific Assisted Medicine in Sao Paulo, Brazil.

Regenstrief's Vice President for Research, Eneida Mendonca, M.D., PhD, will speak Thursday, Oct. 17 and Friday, Oct. 18, about the current research landscape around artificial intelligence in natural language processing.

Dr. Mendonca is a pioneer in employing natural language processing to improve health and healthcare delivery. Her research focuses on language-driven approaches to support decision making, exploiting semantic methods to extract data from patients records, and improving infrastructure for research.

Umberto Tachinardi, M.D., Regenstrief Institute's chief information officer, will discuss the challenges in building data infrastructure to support precision medicine and learning health systems. Dr. Tachinardi has successfully developed and implemented health informatics technologies in organizations of all sizes.

Before coming to Regenstrief, he was responsible for building and operating University of Wisconsin Health's translational research resources, which included data warehouses and new functions in the electronic health record systems.

The workshop is aimed at researchers, teachers and students interested in discussing aspects of data modeling, simulation, visualization and analysis and machine learning.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Researchers aim to use AI for early screening and prognosis of Dry Eye Disease